Chartwell Investment Partners’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Chartwell Investment Partners’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-46,229	Closed	-$944K	–	481
2018 Q3	$944K	Buy	46,229 +685	+2%	+$14.1K	0.03%	444
2018 Q2	$729K	Sell	45,544 -4,119	-8%	-$58.8K	0.02%	462
2018 Q1	$711K	Sell	49,663 -61,908	-55%	-$845K	0.02%	388
2017 Q4	$1.46M	Sell	111,571 -96,518	-46%	-$1.73M	0.05%	360
2017 Q3	$4M	Buy	+208,089	New	+$4.49M	0.14%	222

Other funds holding NITE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Chartwell Investment Partners's NITE Position: Q4 2018 in Review

Chartwell Investment Partners sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2018, closing a stake of 46,229 shares — an estimated $944K sold.

Chartwell Investment Partners first reported a position in NITE in Q3 2017 and held it in 5 quarters. The position peaked at $4M in Q3 2017. 29 funds tracked by Wall St. Rank hold NITE as of Q4 2018.

Chartwell Investment Partners reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Chartwell Investment Partners sold 46,229 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2018, an estimated $944K.
Chartwell Investment Partners first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 5 quarters.
Chartwell Investment Partners's Nightstar Therapeutics plc American Depositary Shares position peaked at $4M in Q3 2017.
29 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2018.

Based on Chartwell Investment Partners's 13F filing for Q4 2018, filed 1 Feb 2019.